Synergistic activity of activin A and basic fibroblast growth factor on tyrosine hydroxylase expression through Smad3 and ERK1/ERK2 MAPK signaling pathways

Journal of Endocrinology

Volumn 184, Issue 3, 2005, Pages 493-504

  Bao, Y L ^b,c   Tsuchida, K ^b   Liu, B ^a   Kurisaki, A ^b   Matsuzaki, T ^b,d   Sugino, H ^b  

^a JILIN UNIVERSITY   (China)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c NORTHEAST NORMAL UNIVERSITY   (China)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; ACTIVIN A; BASIC FIBROBLAST GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROTRANSMITTER; SMAD3 PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; BRAIN NERVE CELL; CELL SURVIVAL; CELL TRANSPORT; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; ENZYME ACTIVATION; FEMALE; GENE ACTIVITY; HIPPOCAMPUS; MOUSE; NERVE CELL; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ACTIVINS; ANIMALS; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; DNA-BINDING PROTEINS; DRUG SYNERGISM; FIBROBLAST GROWTH FACTOR 2; IMMUNOHISTOCHEMISTRY; INHIBIN-BETA SUBUNITS; MAP KINASE SIGNALING SYSTEM; MICE; NEURONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SMAD3 PROTEIN; STIMULATION, CHEMICAL; TRANS-ACTIVATORS; TYROSINE 3-MONOOXYGENASE;

EID: 15844405843     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.05978     Document Type: Article

References (37)

1. Ahn NG, Weiel JE, Chan CP & Krebs EG 1990 Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. Journal of Biological Chemistry 265 11487-11494.
2. Albert KA, Helmer-Matyjek NE, Nairn AC, Muller TH, Haycock JW, Greene LA, Goldstein M & Greengard P 1984 Calcium/phospholipid-dependent protein kinase (protein kinase C) phosphorylates and activates tyrosine hydroxylase. PNAS 81 7713-7717.
3. Cameron VA, Nishimura E, Mathews LS, Lewis KA, Sawchenko PE & Vale WW 1994 Hybridization histochemical localization of activin receptor subtypes in rat brain, pituitary, ovary and testis. Endocrinology 134 799-808.
4. Campbell DG, Hardie DG & Vulliet PR 1986 Identification of the four phosphorylation sites in the N-terminal. region of tyrosine hydroxylase. Journal of Biological Chemistry 261 10489-10492.
5. Chen YG, Lui HM, Lin SL, Lee JM & Ying SY 2002 Regulation of cell proliferation, apoptosis, and carcinogenesis by activin. Experimental Biology Medicine (Maywood) 227 75-87.
6. Claus P, Werner S, Timmer M & Grothe C 2004 Expression of the fibroblast growth factor-2 isoforms and the FGF receptor 1-4 transcripts in the rat model system of Parkinson's disease. Neuroscience Letters 360 117-120.
7. Du X & Iacovitti L 1995 Synergy between growth factors and neurotransmitters required for catecholamine differentiation in brain neurons. Journal of Neuroscience 15 5420-5427.
8. Ehringer H & Hornykiewicz O 1960 Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system. Klinische Wochenschrift 38 1236-1239.
9. Fann MJ & Patterson PH 1994a Depolarization differentially regulates the effects of bone morphogenetic protein (BMP)-2, BMP-6 and activin A on sympathetic neuronal phenotype. Journal of Neurochemistry 63 2074-2079.
10. Fann MJ & Patterson PH 1994b Neuropoietic cyrokines and activin A differentially regulate the phenotype of cultured sympathetic neurons. PNAS 91 43-47.
11. Fontan A, Rojo A, Sanchez Pernaute R, Hernandez I, Lopez I, Castilla C, Sanchez Albisua J, Perez Higueras A, Al-Rashid I, Rabano A, Gonzalo I, Angeles Mena M, Cools A, Eshuis S, Maguire P, Pruim J, Leenders K & Garcia de Yebenes J 2002 Effects of fibroblast growth factor and glial-derived neurotrophic factor on akinesia, F-DOPA uptake and dopamine cells in parkinsonian primates. Parkinsonism and Related Disorders 8 311-323.
12. Funaba M, Murata T, Fujimura H, Murata E, Abe M & Torii K 1997 Immunolocalization of type I or type II activin receptors in the rat brain. Journal of Neuroendocrinology 9 105-111.
13. Gomez N, Tonks NK, Morrison C, Harmar T & Cohen P 1990 Evidence for communication between nerve growth factor and protein tyrosine phosphorylation. FEBS Letters 271 119-122.
14. Grothe C, Schulze A & Semkova I 2000 The high molecular weight fibroblast growth factor-2 isoforms (21 000 and 23 000 mol. wt) mediate neurotrophic activity on rat embryonic mesencephalic dopaminergic neurons in vitro. Neuroscience 100 73-86.
15. Gudmundsson KR 1967 A clinical survey of parkinsonism in Iceland. Acta Neurologica Scandinavica 33 (Suppl) 1-61.
16. Halloran SM & Vulliet PR 1994 Microtubule-associated protein kinase-2 phosphorylates and activates tyrosine hydroxylase following depolarization of bovine adrenal chromaffin cells. Journal of Biological Chemistry 269 17430-17440.
17. Haycock JW, Ahn NG, Cobb MH & Krebs EG 1992 ERK1 and ERK2, two microtubule-associated protein kinases, mediate the phosphorylation of tyrosine hydroxylase at serine 31 in situ. PNAS 89 2365-2369.
18. Hughes PE, Alexi T, Williams CE, Clark RG & Gluckman PD 1999 Administration of recombinant human activin-A has powerful neurotrophic effects on select striatal phenotypes in the quinolinic acid lesion model of Huntington's disease. Neuroscience 92 197-209.
19. Krieglstein K, Reuss B, Maysinger D & Unsicker K 1998 Transforming growth factor-β mediates the neurotrophic effect of fibroblast growth factor-2 on midbrain dopaminergic neurons. European Journal of Neuroscience 10 2746-2750.
20. L'Allemain G, Sturgill TW & Weber MJ 1991 Defective regulation of mitogen-activated protein kinase activity in a 3T3 cell variant mitogenically nonresponsive to tetradecanoyl phorbol acetate. Molecular and Cellular Biology 11 1002-1008.
21. Lewen A, Soderstrom S, Hillered L & Ebendal T 1997 Expression of serine/threonine kinase receptors in traumatic brain injury. Neuro Report 8 475-479.
22. Mathews L 1994 Activin receptors and cellular signaling by the receptor serine kinase family. Endocrine Reviews 15 310-325.
23. Nagatsu T 1995 Tyrosine hydroxylase: human isoforms, structure and regulation in physiology and pathology. Essays in Biochemistry 30 15-35.
24. Nagatsu. T, Levitt M & Udenfriend S 1964 Tyrosine hydroxylase; the initial step in norepinephrine biosynthesis. Journal of Biological Chemistry 239 2910-2917.
25. Ray LB & Sturgill TW 1988 Insulin-stimulated microtubule-associated protein kinase is phosphorylated on tyrosine and threonine in vivo. PNAS 85 3753-3757.
26. Roberts VJ, Sawchenko PE &Vale W 1991 Expression of inhibin/activin subunit messenger ribonucleic acids during rat embryogenesis. Endocrinology 128 3122-3129.
27. Sabban EL 1997 Control of tyrosine hydroxylase gene expression in chromaffin and PC12 cells. Seminars in Cell and Developmental Biology 8 101-111.
28. Sakurada K, Ohshima-Sakurada M, Palmer TD & Gage FH 1999 Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126 4017-4026.
29. Schubert D, Kimura H, LaCorbiere M, Vaughan J, Karr D & Fischer WH 1990 Activin is a nerve cell survival molecule. Nature 344 868-870.
30. Shoji H, Tsuchicla K, Kishi H, Yamakawa N, Matsuzaki T, Liu Z, Nakamura T & Sugino H 2000 Identification and characterization of a PDZ protein that interacts with activin type 11 receptors. Journal Biological Chemistry 275 5485-5492.
31. Sutherland C, Alterio J, Campbell DG, LeBourdelles B, Mallet J, Haavik J & Cohen P 1993 Phosphorylation and activation of human tyrosine hydroxylase in vitro by mitogen-activated protein (MAP) kinase and MAP-kinase-activated kinases 1 and 2. European Journal of Biochemistry 217 715-722.
32. Tiveron MC, Hirsch MR & Brunet JF 1996 The expression pattern of the transcription factor Phox2a delineates synaptic pathways of the autonomic nervous system. Journal of Neuroscience 16 7649-7660.
33. Tretter YP, Hertel M, Munz B, ten Bruggericate G, Werner S & Alzheimer C 2000 Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo. Nature Medicine 6 812-815.
34. Tsuchida K 2004 Activins, myostatin and related TGF-β family members as novel therapeutic targets for endocrine, metabolic and immune disorders. Current Drug Targets, Immune, Endocrine and Metabolic Disorders 4 157-166.
35. Vulliet PR, Woodgett JR & Cohen P 1984 Phosphorylation of tyrosine hydroxylase by calmodulin-dependent multiprotein kinase. Journal of Biological Chemistry 259 13680-13683.
36. Yamauchi T & Fujisawa H 1979 Regulation of bovine adrenal tyrosine-3-monooxygenase by phosphorylation-dephosphorylation reaction, catalyzed by adenosine 3′,5′-monophosphate-dependent protein kinase and phosphoprotein phosphatase. Journal of Biological Chemistry 254 6408-6413.
37. Zhan X, Plourde C, Hu X, Friesel R & Maciag T 1994 Association of fibroblast growth factor receptor-1 with c-Src: correlates with association between c-Src and cortactin. Journal of Biological Chemistry 269 20221-20224.